The discovery and optimisation of pyrido[2,3-d]pyrimidine-2,4-diamines as potent and selective inhibitors of mTOR kinase

被引：76

作者：

Malagu, Karine ^{[2
]}

Duggan, Heather ^{[2
]}

Menear, Keith ^{[2
]}

Hummersone, Marc ^{[2
]}

Gomez, Sylvie ^{[2
]}

Bailey, Christine ^{[2
]}

Edwards, Peter ^{[2
]}

Drzewiecki, Jan ^{[2
]}

Leroux, Frederic ^{[2
]}

Quesada, Mar Jimenez ^{[2
]}

Hermann, Gesine ^{[2
]}

Maine, Stephanie ^{[2
]}

Molyneaux, Carrie-Anne ^{[2
]}

Le Gall, Armelle ^{[2
]}

Pullen, James ^{[2
]}

Hickson, Ian ^{[2
]}

Smith, Lisa ^{[2
]}

Maguire, Sharon ^{[2
]}

Martin, Niall ^{[2
]}

Smith, Graeme ^{[1
,2
]}

Pass, Martin ^{[1
]}

机构：

[1] AstraZeneca, Macclesfield SK10 4TG, Cheshire, England

[2] KuDOS Pharmaceut Ltd, Cambridge 3B4 0WG, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 20期

关键词：

Antitumour; mTOR; Serine/threonine kinase; SIGNALING FUNCTIONS; MAMMALIAN PROTEIN; RAPAMYCIN; TARGET; WORTMANNIN; LY294002; PATHWAY; S6K1;

D O I：

10.1016/j.bmcl.2009.08.038

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We describe a novel series of potent inhibitors of the kinase activity of mTOR. The compounds display good selectivity relative to other PI3K-related kinase family members and, in cellular assays, inhibit both mTORC1 and mTORC2 complexes and exhibit good antiproliferative activity. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：5950 / 5953

页数：4

共 50 条

[21] SYNTHESIS OF SUBSTITUTED "PYRROLO[2,3-D]PYRIMIDINE-2,4-DIONES
ETSON, SR
MATTSON, RJ
SOWELL, JW
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1979, 16 (05) : 929 - 933
[22] Discovery of pyrido[2,3-d]pyrimidine-based inhibitors of HCV NS5A
DeGoey, David A.
Betebenner, David A.
Grampovnik, David J.
Liu, Dachun
Pratt, John K.
Tufano, Michael D.
He, Wenping
Krishnan, Preethi
Pilot-Matias, Tami J.
Marsh, Kennan C.
Molla, Akhteruzzaman
Kempf, Dale J.
Maring, Clarence J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (12) : 3627 - 3630
[23] Synthesis and anticancer evaluation of diaryl pyrido[2,3-d]pyrimidine /alkyl substituted pyrido[2,3-d]pyrimidine derivatives as thymidylate synthase inhibitors
Kumar, Adarsh
Backer, Nabeel
Paliwal, Harshali
Singh, Ankit Kumar
Debbaraman, Tanushree
Singh, Vikramjeet
Kumar, Pradeep
BMC CHEMISTRY, 2024, 18 (01)
[24] Convenient synthesis of 3-(1-carboxyalkyl)pyrido-[2,3-d]pyrimidine-2,4-diones
Saoud M.
Benabdelouahab F.B.
Guemmout F.E.
Romerosa A.
Chemistry of Heterocyclic Compounds, 2002, 38 (03) : 306 - 309
[25] Discovery of novel c-Met kinase inhibitors bearing a thieno[2,3-d]pyrimidine or furo[2,3-d]pyrimidine scaffold
Zhao, Ailing
Gao, Xin
Wang, Yuanxiang
Ai, Jing
Wang, Ying
Chen, Yi
Geng, Meiyu
Zhang, Ao
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (13) : 3906 - 3918
[26] SYNTHESIS OF NEW 1H,3H-PYRIDO[2,3-D]PYRIMIDINE-2,4-DIONES
BRUNEL, S
MONTGINOUL, C
TORREILLES, E
GIRAL, L
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1980, 17 (02) : 235 - 240
[27] PYRIMIDINES .32. SYNTHESIS AND PROPERTIES OF PYRIDO[2,3-D]PYRIMIDINE-2,4-DIONES (5-DEAZALUMAZINES)
PFLEIDERER, M
PFLEIDERER, W
HETEROCYCLES, 1992, 33 (02) : 905 - 929
[28] Synthesis, in vitro, and in vivo characterization of pyrido[2,3-D]pyrimidine tyrosine kinase inhibitors.
Veach, DR
Lambek, C
Liu, CY
Duyster, J
Beresten, T
Li, WQ
Wolff, NC
Ilaria, RL
Gelovani, J
Miller, WT
von Bubnoff, N
Bornmann, WG
Clarkson, BD
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U12 - U12
[29] ENAMINOKETONES .4. 1,2,3,4-TETRAHYDRO-PYRIDO 2,3-D!-PYRIMIDINE-2,4-DIONES
JUNEK, H
WRTILEK, I
MONATSHEFTE FUR CHEMIE, 1970, 101 (04): : 1130 - &
[30] Synthesis of Pyrano[2,3-d]pyrimidine-2,4-diones and Pyridino[2,3-d]pyrimidine-2,4,6,8-tetraones: Evaluation Antitumor Activity
Haggam, Reda A.
Assy, Mohamed G.
Mohamed, Enaiat K.
Mohamed, Abdussattar S.
JOURNAL OF HETEROCYCLIC CHEMISTRY, 2020, 57 (02) : 842 - 850

← 1 2 3 4 5 →